Recent studies have shown that some forms of cannabis, particularly cannabidiol (CBD) and terpenes, can treat COVID-19 in some patients. Research has mainly focused on the treatment of “cytokine storms” — a severe immune reaction that can damage the lungs and lead to acute respiratory distress syndrome (ARDS).
All research is preliminary at this point. Experts from the University of Nebraska and the Texas Biomedical Research Institute recently argued in a paper published in Brain, Behavior, and Immunity that such research is needed because earlier studies have shown CBD can treat COVID-19 patients.
CBD “has shown beneficial anti-inflammatory effects in pre-clinical models of various chronic inflammatory diseases,” the researchers write. New studies have started to find out if this also holds true with treating the coronavirus.
Israeli study investigates the efficacy of cannabis terpenes.
In Israel, two cannabis research and development firms, Eybna and CannaSoul,…